How do you get board approval for fractional CRO spend before signing?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has spent 25 years turning messy revenue orgs into predictable ones, and he brings that same operator instinct to the exact question you are weighing right now.

👉 See Kory White on LinkedIn

The Board’s Buying Committee: Who Actually Decides and What They Care About

The buying committee for a fractional CRO at Series A is not a classic procurement team - it is the board of directors, typically composed of the lead investor (often a partner at a venture firm), one or two independent board members with operating experience, and the founder/CEO who is the primary sponsor. The lead investor holds the most sway because they control the capital allocation and have the strongest opinion on whether the company should be spending on revenue leadership at this stage. The independent board members act as the reality check - they have seen dozens of similar hires fail because the founder wanted a “silver bullet” to fix a broken sales process, and they will push back if the fractional CRO’s scope is not tightly defined.

The typical deal size for a fractional CRO engagement at this stage is $150-300K total over 6-9 months, paid monthly with no upfront retainer (to align risk). The budget approval process is not a formal line-item vote - it is a discussion during a board meeting where the founder presents a one-page memo that shows: (1) why the current sales motion is stalling (e.g., 6-month sales cycles, 40% demo-to-close rate, no repeatable outbound), (2) why a full-time VP of Sales would be premature (e.g., not enough pipeline to justify $200K base salary plus equity), and (3) exactly what the fractional CRO will deliver in measurable terms (e.g., a 90-day sales process audit, a hiring plan for the first two AEs, a closed-won revenue target of $1.2M in the first 6 months).

Where deals stall is on the “what happens after” question - the board wants to know if the fractional CRO will become a permanent expense. The lead investor will ask: “If we approve this, how do we know we won’t be renewing this contract in 12 months because you never learned to hire a real VP of Sales?” The answer must show a clear exit path - a specific trigger event (e.g., hitting $12M ARR or 3 consecutive months of 20% MoM pipeline growth) that forces a decision to convert the fractional role to a full-time hire or end the engagement. If the founder cannot articulate that trigger, the board will treat the fractional CRO as a recurring cost and reject the spend.

The Sales Cycle Implications This Motion Forces

A fractional CRO at Series A creates a unique sales cycle dynamic because the founder is still the primary closer, but the fractional CRO is responsible for building the system around them. The motion forces the founder to step back from day-to-day deal management and focus on strategic accounts, while the fractional CRO takes over pipeline generation, sales process design, and AE hiring. This is uncomfortable for most founders because they are used to controlling every deal, and the fractional CRO will initially face resistance from the founder who wants to micromanage the sales process.

The ramp for a fractional CRO is compressed - they have 30 days to diagnose the current sales motion, 60 days to implement changes (e.g., new qualification criteria, a CRM overhaul, a lead scoring model), and 90 days to show measurable improvement in pipeline velocity or conversion rates. The forecast behavior changes because the fractional CRO will introduce a disciplined forecast process (e.g., weekly pipeline reviews with commit tiers, a 3-month rolling forecast) that the founder may have been avoiding. The pipeline shape shifts from a founder-driven “spray and pray” approach (where the founder chases any inbound lead) to a structured outbound motion with target accounts, ICP definition, and a clear handoff from marketing to sales.

The leaks are predictable: (1) the founder continues to close deals outside the new process, undermining the fractional CRO’s authority; (2) the fractional CRO focuses on process design instead of actually coaching the founder on how to close, so pipeline grows but conversion rates do not; (3) the AE hires made by the fractional CRO fail because the founder did not give them enough leads or support; (4) the board loses patience after 6 months if ARR growth does not accelerate, even if the fractional CRO has improved efficiency metrics. The biggest leak is that the founder treats the fractional CRO as a “fix it for me” hire rather than a “teach me how to fix it” hire - if the founder does not learn the skills to eventually hire a full-time VP of Sales, the engagement will fail regardless of the fractional CRO’s performance.

What a Fractional CRO Looks Like Here: First 90 Days, Operating Cadence, and Ownership

The fractional CRO in this Series A scenario is not a traditional sales executive - they are a blend of sales coach, process architect, and interim operator. Their first 90 days must be structured around three phases: diagnosis (days 1-30), implementation (days 31-60), and validation (days 61-90). In the diagnosis phase, they spend the first two weeks shadowing the founder on every call, reviewing the last 50 closed-won and closed-lost deals, and interviewing the existing AEs (if any) to understand what is actually happening in the sales process. They produce a one-page “state of sales” report that identifies the top three bottlenecks (e.g., no qualification framework, no defined buyer personas, no post-demo follow-up process) and presents it to the founder and board within 30 days.

The operating cadence is intense but structured: weekly 90-minute pipeline reviews with the founder and any AEs, bi-weekly board updates via email (not meetings) with pipeline metrics and forecast changes, and monthly 30-minute board calls focused on progress against the 90-day plan. The fractional CRO owns the sales process, the CRM hygiene, the lead scoring model, and the hiring plan for the first two AEs. They advise on deal strategy (e.g., which deals the founder should personally close, which to delegate) but do not own the founder’s deals - the founder remains the primary closer for the first 6 months. The fractional CRO also owns the metrics dashboard: pipeline coverage ratio (should be 3x the quarterly target), average sales cycle length (target: reduce from current to 90 days), demo-to-close rate (target: improve from current to 25%+), and AE ramp time (target: 60 days to first deal for new hires).

The signals to convert to full-time or not are binary and must be defined in the initial board memo. Convert to full-time if: (1) ARR grows from $5-10M to $12-15M during the engagement, (2) the founder can step back from closing and focus on product or fundraising, (3) the fractional CRO has hired and ramped at least two AEs who are hitting quota, and (4) the board agrees that the company needs a permanent revenue leader to reach $30M+ ARR. Do not convert if: (1) ARR growth is flat or negative after 6 months, (2) the founder is still closing 80%+ of deals, (3) the AEs hired by the fractional CRO have not ramped, or (4) the founder realizes they want to remain the primary closer and hire a VP of Sales who is more of an operator than a strategist. The worst outcome is converting the fractional CRO to full-time without a clear mandate - this creates a situation where the company has an expensive full-time executive who is still treated as a contractor by the founder, leading to conflict and eventual termination.

The Budget Approval Mechanics: How to Frame the Spend to the Board

The board will not approve a fractional CRO spend based on a generic “we need sales help” argument - they need to see a specific ROI calculation tied to the Series A runway. The standard approach is to show that the fractional CRO will cost $150-300K over 6-9 months, but that this spend is offset by a projected $1-2M in incremental ARR from improved conversion rates and pipeline velocity. You must present a before-and-after scenario: before the fractional CRO, the company is burning $200K/month with $500K in monthly recurring revenue (MRR) and no growth acceleration; after the fractional CRO, the company should see $600K MRR within 6 months (a 20% increase) while keeping burn flat. The board will then calculate the payback period - if the fractional CRO costs $30K/month and generates $100K/month in incremental MRR, the payback is less than one month, which is a no-brainer.

The budget approval also requires a “worst case” scenario: what happens if the fractional CRO fails? The board wants to see that the company can still survive without the spend - you must show that the current burn rate does not require the fractional CRO to succeed, but that the upside justifies the risk. The best way to frame this is to carve out the fractional CRO spend from the core operating budget - treat it as a “growth experiment” with a defined stop-loss (e.g., if after 3 months there is no improvement in pipeline coverage or conversion rates, the engagement ends with only a 30-day notice). This gives the board an off-ramp and reduces their fear of sunk-cost fallacy.

The board will also evaluate the fractional CRO’s compensation structure - they want to see that the fractional CRO is incentivized to achieve outcomes, not just to show up. The ideal structure is a base fee ($15-20K/month) plus a performance bonus tied to specific milestones (e.g., $10K bonus for hitting $1M in closed-won revenue, $5K bonus for hiring two AEs who hit quota in their first 90 days). This aligns the fractional CRO with the board’s goal of capital efficiency and ensures that the engagement is not just a retainer for advice.

The Founder’s Role in the Approval Process: What You Must Do Before the Board Meeting

The founder cannot delegate the board approval process to the fractional CRO candidate - the founder must be the one presenting the case, because the board trusts the founder’s judgment more than an external consultant. Before the board meeting, the founder should have a pre-meeting with the lead investor to walk through the one-page memo and get preliminary buy-in. This pre-meeting is where you surface objections (e.g., “I’ve seen this fail before because the founder didn’t actually follow the process”) and address them before the full board meeting. The founder should also have a reference call with another founder who has used a fractional CRO at a similar stage - the board will ask for this reference, so have it ready.

The founder must also demonstrate that they have tried cheaper alternatives first. The board will ask: “Why not hire a sales consultant for $10K to audit the process? Why not promote an existing AE to sales manager? Why not just do it yourself?” The answer must show that the problem is not just process - it is a leadership gap that requires someone who has built a sales function from scratch at Series A before. The founder should also show that they have a learning plan: they will attend the fractional CRO’s pipeline reviews, they will read the same sales methodology books, and they will spend 2 hours per week with the fractional CRO on “coaching the coach” sessions. This signals to the board that the founder is not abdicating responsibility - they are using the fractional CRO as a tool to learn how to eventually hire a full-time VP of Sales.

Finally, the founder must have a clear timeline for the board’s next decision point. The board approval should not be open-ended - it should be a 6-month pilot with a formal review at the 5-month mark where the board decides whether to extend, convert, or terminate. This gives the board a sense of control and reduces the fear that the fractional CRO will become a permanent cost. The founder should also commit to a specific metric that will trigger the review (e.g., “If we hit $12M ARR before the 6-month mark, we will convert the fractional CRO to full-time immediately; if we are below $8M ARR, we will end the engagement and go back to a founder-led sales model”).

The Hidden Risk: How the Fractional CRO Can Undermine Board Confidence

The fractional CRO can actually damage board confidence if they are not careful about how they communicate with the board. A common mistake is that the fractional CRO goes around the founder and starts sending direct updates to the board, which makes the founder look weak or uninformed. The rule must be: all board communication goes through the founder, and the fractional CRO only speaks in board meetings when explicitly asked. If the fractional CRO creates a separate relationship with the board, the founder loses control of the narrative, and the board will start to question whether the founder is actually leading the company.

Another risk is that the fractional CRO over-promises on pipeline growth. At Series A, the company probably has a small number of accounts (20-50), and the fractional CRO may be tempted to inflate pipeline numbers to look good. If the board sees a 3x pipeline increase but no corresponding revenue growth, they will lose trust in the fractional CRO and, by extension, the founder. The fractional CRO must be disciplined about pipeline quality - they should track not just pipeline value but also pipeline-to-close conversion rates, and they should be transparent about which deals are “real” vs. “aspirational.”

The biggest hidden risk is that the fractional CRO becomes a crutch for the founder. If the founder starts relying on the fractional CRO to close deals, to manage AEs, and to handle board communications, the founder will not develop the skills to eventually run the sales function alone. The board will see this dependency and will start to pressure the founder to make the fractional CRO full-time, which may not be the right move for the company. The best fractional CROs actively push the founder to take ownership - they say things like “I’ll design the process, but you need to run the pipeline review this week” - and if the founder is not growing, the board should end the engagement early.

FAQ

A question: What if the board says “just hire a full-time VP of Sales instead”?

The board’s instinct to hire full-time comes from a belief that fractional leaders lack commitment. Counter by showing that a full-time VP of Sales at Series A would cost $200-250K base plus 1-2% equity, which is $400-500K total cost over 12 months, while the fractional CRO costs $150-300K with no equity and no severance risk. Also show that the company does not yet have the pipeline to support a full-time VP - a VP of Sales needs at least $1M in qualified pipeline to hit their first quarter, and if you only have $300K, they will fail. The fractional CRO builds the pipeline first, then the full-time hire inherits a functioning machine.

A question: How do we evaluate fractional CRO candidates before the board meeting?

Evaluate them on three criteria: (1) Have they built a sales function at a similar stage company before (Series A, $5-10M ARR, founder-led sales)? (2) Can they articulate a specific 90-day plan for your company, not a generic “I’ll fix sales” pitch? (3) Do they have references from founders who used them as a fractional CRO, not as a full-time employee? The best candidates will offer to do a free 2-hour sales audit before you sign, which gives you a sample of their work. Avoid candidates who only want to talk about their past full-time roles at large companies - they will not understand the resource constraints of a Series A startup.

A question: What if the fractional CRO wants equity as part of the deal?

Never give equity to a fractional CRO at Series A. Equity is for full-time employees who will be with the company for 4+ years and whose incentives are aligned with long-term value creation. A fractional CRO is a temporary contractor - their incentives should be aligned via cash bonuses tied to specific milestones (e.g., $10K for hitting $1M in closed revenue). If they push for equity, it signals that they want to be a full-time employee but are not willing to commit, which is a red flag. The board will reject any equity grant for a fractional role because it sets a precedent that other contractors will also demand equity.

A question: How do we handle the founder’s ego during the fractional CRO engagement?

The founder’s ego is the single biggest risk to the engagement. The founder must accept that they are not the best salesperson in the company - if they were, the company would already be growing faster. The fractional CRO should position themselves as the founder’s coach, not their boss, and should always let the founder take credit for wins. The founder should commit to a “no veto” rule for the first 90 days: they will follow the fractional CRO’s process even if they disagree, and they will only escalate disagreements to the board if the process is clearly failing. If the founder cannot do this, the fractional CRO will quit within 3 months, and the board will have wasted the spend.

Sources